User:Camille Zumstein/Sandbox

spinqualitylabelsall models Rat calcineurin monomer Show:Asymmetric Unit Biological Assembly Drag the structure with the mouse to rotate   Export Animated Image

You may include any references to papers as in: the use of JSmol in Proteopedia ^[1] or to the article describing Jmol ^[2] to the rescue.

Calcineurin is a serine/threonine phosphatase that is activated by calmodulin in a calcium-dependant manner. Calcineurin is the only known calmodulin-activated protein phosphatase. Calcineurin is responsible mainly for dephosphorylating several member of the NFAT transcription factor family (including NFATc1 through NFATc4).

Localisation and expression:

Calcineurin is a cytoplasmic protein. The catalytic subunit calcineurin A, posses two major isoforms called calcineurin Aα and Aβ. Calcineurin Aα is widely expressed among tissues especially in the Central Nervous System (CNS). Calcineurin Aβ is rather found in the lymphoid cells.Calcineurin Aβ is therefore involved in the mediation of the immune response ^[3].

Contents 1 Function 2 General structure 3 Principle of action 4 Addictional structural highlights 5 Binding Partners 6 Related health defects

Function

General structure

is a heterodimeric Protein that consits of two subunits. They are called catalytic and regulatory subunit. Four molecules of Calcineurin form a asymmetric complex which leads to a total molecular weight of 370 kDa.

The structure presented in this article is the catalytic subunit isoform of the serine/threonine-protein phosphatase 2B in rattus norvegicus (rat). It consists of 521 ^[4] aminoacids and has a molecular weight of 57 kDa ^[5].

The calatytic subunit is subdivided into functional domains which are a , a , a and an .

The catalytic side includes a residue (green) at position 151 that acts as proton donor and metal binding sites. (shown in brown) binds at the position 118, 150, 199 and 281. Iron (blue) interacts at the positions 90, 92 and 118.

are modified with a serine or a tyrosine. At position 2, a N-acetylserine has been found by similarity, as well as a nitrated tyrosine at position 224, and phosphoserine at position 469 and 492.

Discovery of the structure:

The structure have been published in the year 2013 by Qilu Ye et al. ^[6]. For their experiments they used x-ray diffraction. The PDB validation obtained a Resolutionof 3.0 Å, a free R-value of 0.273 and a work R-value of 0.241 ^[7].

secondary structure:

Besides, there are six turns reported in the structure of a chain.

The Ramachandran blot of Calcineurin has been obtained by MolProbity of the DUke University. It plots the torsional angles phi (φ)and psi (ψ)of the molecule and thereby represents the secondary structure. Further information about the Interpretation of this plot can be found at Ramachandran Plot.

Principle of action

It has been reported that Calcineurin activates the transcription factor NFAT by forming a complex and dephosporylation ^[8]. Following, the factor enters the nucleus and activates the expression of Interleukin-2.

Addictional structural highlights

This is a sample scene created with SAT to by Group, and another to make of the protein. You can make your own scenes on SAT starting from scratch or loading and editing one of these sample scenes.

Binding Partners

The main partners of interaction are Calmodulin,NFATc1, NFATc2 and NFATc3. Many of the calcineurin substrates’ contain a PxIxIT motif. Among them, beside the phosphorylated forms of NFAT we can also mentioned; cAMP response element binding (CREB), PP1, microtubule-associated protein tau and glycogen synthase kinase-3 beta (GSK- 3)^[9]. Calcineurin is inhibited by the immunosuppressive drugs tacrolismus (FK506) or cyclosporine A (CsA). CsA and FK506 conduct their therapeutic role thought binding to the immunophilins cyclophilin and FK506 binding protein (FK506BP) respectively. The complexes CsA-cyclophilin and FK506-FK506BP bind then to calcineurin in a calcium-dependent manner thus inhibiting its phosphatase activity. Therefore the addition of these drugs to lymphocytes T prevent NFAT translocation to the nucleus and the subsequent activation its target gene.That's why FK506 and CsA are use in the treatment of various immune-mediated diseases. However since calcineurin is is widely expressed in non-haemopoietic tissues like the kidney and the hearth, both drugs present a long term toxicity and can lead to deleterious effect to these organs^[10], ^[11].

Cofactors:

Calcineurin belong to the family of metalloprotein. To conduct its activity it requires the presence of Fe3+ and Zn2+ ions in the active site (one per subunit).Superoxide dismutase has been shown to protect calcineurin from inactivation by preventing Fe3+ from oxidation. Thus after activation of calcineurin by calmodulin, the AID is displaced from the catalytic core exposing Fe3+ to oxidation^[12][13].

Related health defects

Calcineurin hyperactivation thought dysregulation of the Ca2+ dynamic have been show to play a critical role in several diseases like Rheumatoid arthritis (RA), Schizophrenia ,Diabetes, Systemic Lupus Erythematosus as well as Alzheimer diseases ^{[14][15] [16]}, ^[17][18].In order to fight those health defects calmodulin inhibitors can be administrated.